Want to track FRE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 36 days
Summary
FRE closed Friday higher at €42.59, an increase of 0.95% from Thursday's close, completing a monthly decrease of -1.37% or €0.59. Over the past 12 months, FRE stock gained 27.1%.
FRE pays dividends to its shareholders, with the most recent payment made on May 28, 2025. The next estimated payment will be in 1 month ago on May 28, 2025 for a total of €1.
The last earnings report, released on May 07, 2025, exceeded the consensus estimates by 0.09%. On average, the company has fell short of earnings expectations by -0.47%, based on the last three reports. The next scheduled earnings report is due on Aug 05, 2025.
Fresenius SE & Co. KGaA has completed 1 stock splits, with the recent split occurring on Aug 04, 2014.
The company's stock is traded on 11 different exchanges and in various currencies, with the primary listing on XWBO (EUR).
FRE Chart
Fresenius SE & Co. KGaA Dividends
 FRE 30 Nov 2026 Estimated | Final | €1 Per Share |
| FRE 1 month ago Paid | Final | €1 Per Share |
| FRE 18 May 2023 Paid | Final | €0.92 Per Share |
| FRE 16 May 2022 Paid | Final | €0.92 Per Share |
| FRE 25 May 2021 | Other | €0.77 Per Share |
| FRE 24 May 2021 Paid | Final | €0.88 Per Share |
Fresenius SE & Co. KGaA Earnings
| 6 Aug 2025 (In 1 month) Date | | 0.82 Cons. EPS | - EPS |
| 5 Aug 2025 (In 1 month) Date | | 0.8 Cons. EPS | - EPS |
| 7 May 2025 Date | | 0.78 Cons. EPS | 0.87 EPS |
| 1 May 2025 Date | | 0.83 Cons. EPS | - EPS |
| 26 Mar 2025 Date | | 0.68 Cons. EPS | - EPS |
| FRE 30 Nov 2026 Estimated | Final | €1 Per Share |
| FRE 1 month ago Paid | Final | €1 Per Share |
| FRE 18 May 2023 Paid | Final | €0.92 Per Share |
| FRE 16 May 2022 Paid | Final | €0.92 Per Share |
| FRE 25 May 2021 | Other | €0.77 Per Share |
| FRE 24 May 2021 Paid | Final | €0.88 Per Share |
| 6 Aug 2025 (In 1 month) Date | | 0.82 Cons. EPS | - EPS |
| 5 Aug 2025 (In 1 month) Date | | 0.8 Cons. EPS | - EPS |
| 7 May 2025 Date | | 0.78 Cons. EPS | 0.87 EPS |
| 1 May 2025 Date | | 0.83 Cons. EPS | - EPS |
| 26 Mar 2025 Date | | 0.68 Cons. EPS | - EPS |
Fresenius SE & Co. KGaA (FRE) FAQ
What is the stock price today?
The current price is €42.59.
On which exchange is it traded?
Fresenius SE & Co. KGaA is listed on XWBO.
What is its stock symbol?
The ticker symbol is FRE.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 0.67%.
What is its market cap?
As of today, no market cap data is available.
What is the earnings per share?
The EPS is 0.8.
When is the next earnings date?
The next earnings report will release on Aug 05, 2025.
Has Fresenius SE & Co. KGaA ever had a stock split?
Fresenius SE & Co. KGaA had 1 splits and the recent split was on Aug 04, 2014.
Fresenius SE & Co. KGaA Profile
| Medical Care Facilities Industry | Healthcare Sector | Mr. Michael Sen CEO | XETRA Exchange | DE0005785604 ISIN |
| Germany Country | 177,091 Employees | 23 Aug 1970 Last Dividend | - Last Split | - IPO Date |
Overview
Fresenius SE & Co. KGaA is a leading health care company specializing in providing a wide range of products and services for chronically ill patients. With its operations divided into four primary segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed, the company caters to the varied needs of patients worldwide. Fresenius Medical Care focuses on offering solutions for those suffering from chronic kidney failure, while Fresenius Kabi is dedicated to the therapy and care of critically and chronically ill patients through its range of drugs, nutrition products, and medical technologies. Fresenius Helios operates clinical and nursing care facilities, and Fresenius Vamed delivers services for hospitals and other healthcare facilities, including operational management. Established in 1912 and formerly known as Fresenius SE, the company underwent a name change in January 2011 to Fresenius SE & Co. KGaA. Headquartered in Bad Homburg vor der Höhe, Germany, Fresenius stands as a testament to innovation and dedication in the healthcare sector.
Products and Services
- Fresenius Medical Care: Focuses on patients with chronic kidney failure, offering dialysis machines, dialyzers, related disposable products, and dialysis-related services. This comprehensive range is designed to improve the quality of life for patients undergoing dialysis treatment.
- Fresenius Kabi: Specializes in the care of critically and chronically ill patients by providing:
- I.V. Generic Drugs: A variety of intravenous generic medications tailored to meet the needs of patients and healthcare providers.
- Biosimilar Drugs: Treatments for autoimmune diseases and oncology, offering cost-effective alternatives to biologic drugs while maintaining quality and efficacy.
- Enteral and Parenteral Nutrition Products: Essential nutrition solutions for patients who cannot eat normally, ensuring they receive the necessary nutrients.
- Medical Technologies and Disposables: Including infusion pumps, apheresis machines, and cell therapy devices, supporting advanced patient care.
- Fresenius Helios: Provides clinical and nursing care facilities, ensuring high-quality care and services for patients and facilitating a holistic approach to health recovery and management.
- Fresenius Vamed: Offers services for hospitals and other healthcare facilities ranging from operational management to comprehensive care services, aimed at optimizing healthcare delivery and patient experience.
Contact Information
Address: Else-Kroener-Strasse 1
Phone: 49 6172 6080
Website: https://www.fresenius.com
2025 © Marketlog. All Rights Reserved.
